Social, economic, and policy implications of organ preservation advances

被引:28
作者
Ward, Alyssa [1 ]
Klassen, David K. [2 ]
Franz, Kate M. [1 ]
Giwa, Sebastian [3 ,4 ]
Lewis, Jedediah K. [1 ]
机构
[1] Organ Preservat Alliance, NASA Res Pk, Los Altos, CA 94035 USA
[2] United Network Organ Sharing, Richmond, VA USA
[3] Sylvatica Biotech Inc, Charleston, SC USA
[4] Ossium Hlth, San Francisco, CA USA
关键词
cryopreservation; organ banking; perfusion; tissue preservation; VIVO LUNG PERFUSION; HYPOTHERMIC MACHINE PRESERVATION; MISMATCHED RENAL-TRANSPLANTATION; HEART-TRANSPLANTATION; CIRCULATORY DEATH; NORMOTHERMIC PERFUSION; KIDNEY-TRANSPLANTATION; LIVER-TRANSPLANTATION; DONOR; DONATION;
D O I
10.1097/MOT.0000000000000532
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Purpose of reviewDespite over 60 years of progress in the field of since the first organ transplant, insufficient organ preservation capabilities still place profound constraints on transplantation. These constraints play multiple and compounding roles in the predominant limitations of the field: the severe shortages of transplant organs, short-term and long-term posttransplant outcomes and complications, the unmet global need for development of transplant infrastructures, and economic burdens that limit patient access to transplantation and contribute to increasing global healthcare costs. This review surveys ways that advancing preservation technologies can play a role in each of these areas, ultimately benefiting thousands if not millions of patients worldwide.Recent findingsPreservation advances can create a wide range of benefits across many facets of organ transplantation, as well as related areas of transplant research. As these technologies mature, so will the policies around their use to maximize the benefits offered by organ preservation.SummaryOrgan preservation advances stand to increase local and global access to transplantation, improve transplant outcomes, and accelerate progress in related areas such as immune tolerance induction and xenotransplantation. This area holds the potential to save the healthcare system many billions of dollars and reduce costs across many aspects of transplantation. Novel preservation technologies, along with other technologies facilitated by preservation advances, could potentially save millions of lives in the coming years.
引用
收藏
页码:336 / 346
页数:11
相关论文
共 143 条
[1]   Individualized immunosuppression in transplant patients: potential role of pharmacogenetics [J].
Abboudi, Hamid ;
MacPhee, Iain A. M. .
PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2012, 5 :63-72
[2]   The effect of ex vivo lung perfusion on microbial load in human donor lungs [J].
Andreasson, Anders ;
Karamanou, Danai M. ;
Perry, John D. ;
Perry, Audrey ;
Oezalp, Faruk ;
Butt, Tanveer ;
Morley, Katie E. ;
Walden, Hannah R. ;
Clark, Stephen C. ;
Prabhu, Mahesh ;
Corns, Paul A. ;
Gould, Kate ;
Fisher, Andrew J. ;
Dark, John H. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (09) :910-916
[3]  
[Anonymous], LIFEPORT KIDN TRANSP
[4]  
[Anonymous], GLOB OBS DON TRANSPL
[5]  
[Anonymous], NEWS OF AFRICA
[6]  
[Anonymous], DONOR MANAGEMENT RES
[7]  
[Anonymous], DAT REP NAT DAT
[8]  
[Anonymous], ANN SURG
[9]  
[Anonymous], OPTN SRTR ANN REP 20
[10]  
[Anonymous], LIFEPORT LIV TRANSP